Apellis Pharmaceuticals
APLS
$49.86
Share price
4.03%
Change (1 day)
-39.77%
Change (1 year)
Categories
Apellis Pharmaceuticals (APLS) - P/B ratio
P/B ratio as of April 2024 : 30.9
According to Apellis Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 30.9.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Apellis Pharmaceuticals - P/B ratio (from 2017 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 36.5 | 8.34% |
| 2022-12-31 | 33.7 | 45.27% |
| 2021-12-31 | 23.2 | 9.41% |
| 2020-12-31 | 21.2 | -62.97% |
| 2019-12-31 | 57.2 | 1140.31% |
| 2018-12-31 | 4.61 | -37.12% |
| 2017-12-31 | 7.33 | |
| 2016-12-31 | N/A | |
| 2015-12-31 | N/A | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.43 | -92.15% | 🇺🇸 USA |